{"nct_id":"NCT02927873","title":"A Study to Evaluate Safety, Reactogenicity and Immunogenicity of GSK Biologicals' RSV Investigational Vaccine Based on Viral Proteins Encoded by Chimpanzee-derived Adenovector (ChAd155-RSV) (GSK3389245A) in RSV-seropositive Infants","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2017-01-11","start_date_type":"ACTUAL","primary_completion_date":"2019-02-19","primary_completion_date_type":"ACTUAL","completion_date":"2020-11-26","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GSK"]}